MachineMD has successfully closed a financing round of CHF 1.4m. We are developing a diagnostic platform for early detection of neurodegenerative diseases based on eye and pupil movements. The market entry is planned for the end of 2023.

The financing of this first closing for the seed round was carried out in the form of a convertible loan. Investors of this first round are physicians who are among machineMD's future target customers, business angels and the location promotion of the Canton of Bern. The funds will mainly be used for product development. The next financing round will complete the seed financing and is planned for Q3/Q4 2022.